Effects of Guangxi Hepu Pearl Hydrolysate on Proliferation Activity and Apoptosis of Human Hepatic Stellate Cells

被引:1
|
作者
Yue Peng [1 ]
Quansheng Feng [2 ]
Jiang Lin [1 ]
Tiejian Zhao [1 ]
Peng Liu [1 ]
Yanhui Cen [1 ]
机构
[1] Guangxi University of Chinese Medicine
[2] Chengdu University of TCM
基金
中国国家自然科学基金;
关键词
Pearls; Hepatic stellate cells; Cell proliferation; Apoptosis; Liver fibrosis;
D O I
10.19579/j.cnki.plant-d.p.2021.03.007
中图分类号
R285 [中药药理学];
学科分类号
1008 ;
摘要
[Objective] The paper was to observe the effects of Guangxi Hepu pearl hydrolysate on proliferation and apoptosis of human hepatic stellate cells. [Method] The inhibition rate against the proliferation of human hepatic stellate cells was determined by MTT colorimetry after co-incubation with pearl hydrolysate for 48 h. The percentage of early and late apoptotic cells was determined by flow cytometry(Annexin V-FITC/PI staining). [Result] Low, medium and high concentrations of pearl hydrolysate could inhibit the proliferation of human hepatic stellate cells, and the inhibition rates at 48 h were 12.4%, 27.4% and 37.8%, respectively. The low, medium and high concentrations of pearl hydrolysate could induce the apoptosis of cells. The percentages of total apoptotic cells(early apoptotic + late apoptotic) at 48 h were 8.97%, 16.09% and 26.98%, respec-tively. [Conclusion] Pearl hydrolysate can inhibit the proliferation of human hepatic stellate cells and induce the apoptosis of these cells, which may be the mechanism of anti-hepatic fibrosis effect of pearl hydrolysate. These effects are dose-dependent. It is also found that the above cellular effects of high dose pearl hydrolysate are stronger than those of colchicine and compound Biejiaruangan tablets.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [41] Effects of PPARα activator on human hepatic stellate cells.
    Ueno, T
    Kimura, R
    Sakata, R
    Nakamura, T
    Koga, H
    Torimura, T
    Sata, M
    HEPATOLOGY, 2002, 36 (04) : 488A - 488A
  • [42] Telomere shortening induces apoptosis in activated human hepatic stellate cells.
    Schnabl, B
    Olsen, JC
    Brenner, DA
    HEPATOLOGY, 2000, 32 (04) : 315A - 315A
  • [43] The effects of different immunoglobulins on the proliferation and activation of rat hepatic stellate cells.
    Shen, H
    Ji, H
    Gong, Y
    HEPATOLOGY, 2002, 36 (04) : 262A - 262A
  • [44] Effects of Shenqi Neijin powder on activation and apoptosis of hepatic stellate cells in rats with hepatic fibrosis
    Xie, Hongdong
    Hou, Wei
    Yang, Yide
    Yu, Ying
    Wang, Fengling
    Mao, Juanjuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2226 - 2232
  • [45] Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation
    Wang, Lin
    Wang, Jian
    Wang, Bao-En
    Xiao, Pei-Gen
    Qiao, Yan-Jiang
    Tan, Xue-Hai
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (19) : 2831 - 2835
  • [46] Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation
    Lin Wang Jian Wang Bao-En Wang Pei-Gen Xiao Yan-Jiang Qiao Xue-Hai Tan School of Chinese Materia Medica
    World Journal of Gastroenterology, 2004, (19) : 2831 - 2835
  • [47] Astrogalosides inhibit proliferation of hepatic stellate cells through inducing apoptosis and blocking cell cycle
    Wu, Q
    Yang, Y
    Chen, MZ
    SHOCK, 2004, 21 : 29 - 29
  • [48] BENEFICIAL EFFECTS OF MULTIKINASE INHIBITOR SORAFENIB ON INHIBITING PROLIFERATION AND INDUCING APOPTOSIS IN HEPATIC STELLATE CELL
    Wang, Yan
    Gao, Juncha
    Jiang, Huiqing
    HEPATOLOGY, 2009, 50 (04) : 839A - 839A
  • [49] Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
    Zhang, Li-Ting
    Peng, Xue-Bin
    Fang, Xue-Qin
    Li, Jun-Feng
    Chen, Hong
    Mao, Xiao-Rong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (05) : 2545 - 2552
  • [50] Demethylbellidifolin Inhibits Proliferation and Activation of Hepatic Stellate Cells
    Li, Jun Fu
    Lu, Gen Fang
    Zou, You Yi
    JOURNAL OF INVESTIGATIVE SURGERY, 2011, 24 (04) : 171 - 177